Influence of the sFlt-1/PlGF ratio on clinical decision-making in women with suspected preeclampsia

PLoS ONE

Volumn 11, Issue 5, 2016, Pages

  Klein, Evelyn ^a   Schlembach, Dietmar ^b,i   Ramoni, Angela ^c   Langer, Elena ^d   Bahlmann, Franz ^e   Grill, Sabine ^a   Schaffenrath, Helene ^c   Van Der Does, Reinhard ^f   Messinger, Diethelm ^f   Verhagen Kamerbeek, Wilma D J ^g   Reim, Manfred ^h   Hund, Martin ^g   Stepan, Holger ^d  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b JENA UNIVERSITY HOSPITAL   (Germany)

^c UNIVERSITY HOSPITAL INNSBRUCK   (Austria)

^d UNIVERSITY OF LEIPZIG   (Germany)

^e Burgerhospital Frankfurt am Main   (Germany)

^f IST GmbH   (Germany)

^g Roche Diagnostics International Ltd   (Switzerland)

^h ROCHE DIAGNOSTICS GMBH   (Germany)

ⁱ Clinic of Obstetrics   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

PLACENTAL GROWTH FACTOR; VASCULOTROPIN RECEPTOR 1; BIOLOGICAL MARKER; FLT1 PROTEIN, HUMAN; PGF PROTEIN, HUMAN;

ACUTE KIDNEY FAILURE; ADULT; ARTICLE; BRAIN HEMORRHAGE; CLINICAL DECISION MAKING; ECLAMPSIA; FEMALE; FETUS LUNG MATURATION; HELLP SYNDROME; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; IMMUNOASSAY ANALYZER; INTRAUTERINE GROWTH RETARDATION; LABOR INDUCTION; LUNG EDEMA; MULTICENTER STUDY (TOPIC); NEONATAL RESPIRATORY DISTRESS SYNDROME; NEWBORN; PREECLAMPSIA; PREGNANT WOMAN; PREMATURE LABOR; PROSPECTIVE STUDY; SOLUBLE FMS LIKE TYROSINE KINASE 1 PLACENTAL GROWTH FACTOR RATIO; CLINICAL TRIAL; METABOLISM; MIDDLE AGED; MULTICENTER STUDY; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY COMPLICATIONS; PROCEDURES; YOUNG ADULT;

ADULT; BIOMARKERS; CLINICAL DECISION-MAKING; FEMALE; HUMANS; MIDDLE AGED; PLACENTA GROWTH FACTOR; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY COMPLICATIONS; PROSPECTIVE STUDIES; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-1; YOUNG ADULT;

EID: 84971624236     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0156013     Document Type: Article

References (28)

1. Powe CE, Levine RJ, Karumanchi SA. Preeclampsia, a disease of the maternal endothelium: the role of antiangiogenic factors and implications for later cardiovascular disease. Circulation. 2011; 123 (24):2856-2869. doi: 10.1161/CIRCULATIONAHA.109.853127 PMID: 21690502
2. Ananth CV, Keyes KM, Wapner RJ. Pre-eclampsia rates in the United States, 1980-2010: age-period-cohort analysis. BMJ. 2013; 347. doi: 10.1136/bmj.f6564
3. Hernández-Díaz S, Toh S, Cnattingius S. Risk of pre-eclampsia in first and subsequent pregnancies: prospective cohort study. BMJ. 2009; 338. doi: 10.1136/bmj.b2255
4. Skjaerven R, Wilcox AJ, Lie RT. The interval between pregnancies and the risk of preeclampsia. N Engl J Med. 2002; 346(1):33-38. PMID: 11778000
5. World Health Organization. The World Health Report 2005 -make every mother and child count. Available: http://www.who.int/whr/2005/en/. Accessed 2015 Jul 1.
6. Meis PJ, Goldenberg RL, Mercer BM, Iams JD, Moawad AH, Miodovnik M, et al. The preterm prediction study: risk factors for indicated preterm births. Am J Obstet Gynecol. 1998; 178(3):562-567. PMID: 9539527
7. Henderson JT, Whitlock EP, O'Connor E, Senger CA, Thompson JH, Rowland MG. Low-dose aspirin for prevention of morbidity and mortality from preeclampsia: a systematic evidence review for the US Preventive Services Task Force. Ann Int Med. 2014; 160(10):695-703. doi: 10.7326/M13-2844 PMID: 24711050
8. Chaiworapongsa T, Chaemsaithong P, Yeo L, Romero R. Pre-eclampsia part 1: current understanding of its pathophysiology. Nat Rev Nephrol. 2014; 10(8):466-480. doi: 10.1038/nrneph.2014.102 PMID: 25003615
9. Makris A, Thornton C, Thompson J, Thomson S, Martin R, Ogle R, et al. Uteroplacental ischemia results in proteinuric hypertension and elevated sFLT-1. Kidney Int. 2007; 71(10):977-984. PMID: 17377512
10. Chaiworapongsa T, Chaemsaithong P, Korzeniewski SJ, Yeo L, Romero R. Pre-eclampsia part 2: prediction, prevention and management. Nat Rev Nephrol. 2014; 10(9):531-540. doi: 10.1038/nrneph.2014.103 PMID: 25003612
11. Levine RJ, Lam C, Qian C, Yu KF, Maynard SE, Sachs BP, et al. Soluble endoglin and other circulating antiangiogenic factors in preeclampsia. N Engl J Med. 2006; 355(10):992-1005. PMID: 16957146
12. Maynard SE, Min JY, Merchan J, Lim KH, Li J, Mondal S, et al. Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J Clin Invest. 2003; 111(5):649-658. PMID: 12618519
13. Levine RJ, Maynard SE, Qian C, Lim KH, England LJ, Yu KF, et al. Circulating angiogenic factors and the risk of preeclampsia. N Engl J Med. 2004; 350(7):672-683. PMID: 14764923
14. Verlohren S, Herraiz I, Lapaire O, Schlembach D, Zeisler H, Calda P, et al. New gestational phase-specific cutoff values for the use of the soluble fms-like tyrosine kinase-1/placental growth factor ratio as a diagnostic test for preeclampsia. Hypertension. 2014; 63(2):346-352. doi: 10.1161/HYPERTENSIONAHA.113.01787 PMID: 24166751
15. Verlohren S, Galindo A, Schlembach D, Zeisler H, Herraiz I, Moertl MG, et al. An automated method for the determination of the sFlt-1/PlGF ratio in the assessment of preeclampsia. Am J Obstet Gynecol. 2010; 202(2):161. doi: 10.1016/j.ajog.2009.09.016 PMID: 19850276
16. Verlohren S, Herraiz I, Lapaire O, Schlembach D, Moertl M, Zeisler H, et al. The sFlt-1/PlGF ratio in different types of hypertensive pregnancy disorders and its prognostic potential in preeclamptic patients. Am J Obstet Gynecol. 2012; 206(1):58. doi: 10.1016/j.ajog.2011.07.037 PMID: 22000672
17. Roche Diagnostics GmbH. Elecsys® PlGF immunoassay. Method Sheet. 2013-08, V 5.
18. Roche Diagnostics GmbH. Elecsys® sFlt-1 immunoassay. Method Sheet. 2013-08, V 5.
19. Roche Diagnostics GmbH. Elecsys® PlGF immunoassay. Method Sheet. 2015-11, V 8.0. Available: https://pim-eservices.roche.com/(S(gg4fofmud4wj1ergwtstk0tz))/pi/en/Documents/GetDocument?documentId=b4d1d21e-03cf-e411-19b6-00215a9b0ba8. Accessed 2016 Mar 12.
20. Roche Diagnostics GmbH. Elecsys® sFlt-1 immunoassay. Method Sheet. 2015-10, V 7.0. Available: https://pim-eservices.roche.com/(S(4kc2ldj0xbihag3v1y4zksbr))/pi/en/Documents/GetDocument?documentId= 394ff5ec-5a4d-e411-9694-00215a9b0ba8. Accessed 2016 Mar 12.
21. Álvarez-Fernández I, Prieto B, Rodríguez V, Ruano Y, Escudero AI, Álvarez FV. New biomarkers in diagnosis of early onset preeclampsia and imminent delivery prognosis. Clin Chem Lab Med. 2014; 52 (8):1159-1168. doi: 10.1515/cclm-2013-0901 PMID: 24516004
22. Ohkuchi A, Hirashima C, Suzuki H, Takahashi K, Yoshida M, Matsubara S, et al. Evaluation of a new and automated electrochemiluminescence immunoassay for plasma sFlt-1 and PlGF levels in women with preeclampsia. Hypertens Res. 2010; 33(5):422-427. doi: 10.1038/hr.2010.15 PMID: 20150910
23. Stepan H, Herraiz I, Schlembach D, Verlohren S, Brennecke S, Chantraine F, et al. Implementation of the sFlt-1/PlGF ratio for prediction and diagnosis of pre-eclampsia in singleton pregnancy: implications for clinical practice. Ultrasound Obstet Gynecol. 2015; 45(3):241-246. doi: 10.1002/uog.14799 PMID: 25736847
24. Hund M, Verhagen-Kamerbeek W, Reim M, Messinger D, Van der Does R, Stepan H. Influence of the sFlt-1/PlGF ratio on clinical decision-making in women with suspected preeclampsia - the PreOS study protocol. Hypertens Pregnancy. 2015; 34(1):102-115. doi: 10.3109/10641955.2014.982331 PMID: 25629903
25. Milne F, Redman C, Walker J, Baker P, Black R, Blincowe J, et al. Assessing the onset of pre-eclampsia in the hospital day unit: summary of the pre-eclampsia guideline (PRECOG II). BMJ. 2009; 339. doi: 10.1136/bmj.b3129
26. Rana S, Powe CE, Salahuddin S, Verlohren S, Perschel FH, Levine RJ, et al. Angiogenic factors and the risk of adverse outcomes in women with suspected preeclampsia. Circulation. 2012; 125(7):911-919. doi: 10.1161/CIRCULATIONAHA.111.054361 PMID: 22261192
27. Zeisler H, Llurba E, Chantraine F, Vatish M, Staff AC, Sennström M, et al. Predictive value of the sFlt-1: PlGF ratio in women with suspected preeclampsia. N Engl J Med. 2016; 374(1):13-22. doi: 10.1056/NEJMoa1414838 PMID: 26735990
28. Chappell LC, Duckworth S, Seed PT, Griffin M, Myers J, Mackillop L, et al. Diagnostic accuracy of placental growth factor in women with suspected preeclampsia: a prospective multicenter study. Circulation. 2013; 128(19):2121-2131. doi: 10.1161/CIRCULATIONAHA.113.003215 PMID: 24190934